Atlas Trials

Fondazione Ricerca Traslazionale

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fondazione Ricerca Traslazionale

RecordFirmDate
Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations. (NCT07392658)Fondazione Ricerca Traslazionale2025-12-02
A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study. (NCT07264673)Fondazione Ricerca Traslazionale2025-04-17
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC) (NCT07264647)Fondazione Ricerca Traslazionale2025-03-27
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab (NCT05568212)Fondazione Ricerca Traslazionale2022-05-02
Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED) (NCT04884282)Fondazione Ricerca Traslazionale2021-10-12
Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB) (NCT06823401)Fondazione Ricerca Traslazionale2021-05-20
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) (NCT03896074)Fondazione Ricerca Traslazionale2020-03-02
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer (NCT04317651)Fondazione Ricerca Traslazionale2019-05-16
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation (NCT03911193)Fondazione Ricerca Traslazionale2018-09-21
An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC) (NCT03823625)Fondazione Ricerca Traslazionale2017-09-13

Track Fondazione Ricerca Traslazionale automatically

Every clearance here is in the API, with alerts when new ones post.